Insider · CIK 0001738374
Jeffrey W. Chell
Files at ATNM (Actinium Pharmaceuticals, Inc.). First filing -, latest -.
Jeffrey W. Chell files SEC Form 4 as director at ATNM (Actinium Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jeffrey W. Chell has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | ATNM Actinium Pharmaceuticals, Inc. | AGrant or award Common Stock | +61,600 | $0.00 | $0 | 61,600 | 39 d ago |
| Sep 2, 2026 | ATNM Actinium Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +92,400 | $0.00 | $0 | 92,400 | 39 d ago |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,351 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -72,156 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,311 | $0.00 | $0 | 0 | Apr 2, 2025 |
Questions about Jeffrey W. Chell
Answered from the filings on this page, as of the latest one.
Is Jeffrey W. Chell buying or selling?
Jeffrey W. Chell has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jeffrey W. Chell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey W. Chell has 0.
Where does Jeffrey W. Chell file Form 4?
Jeffrey W. Chell has filed Form 4 at ATNM (Actinium Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.